Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease
Table 1
Clinical findings of the included 14 TIO cases.
Cases
Age and gender
Osteomalacia duration (year)
Osteoporotic fracture
Tumor location
Tumor size (cm)
Tumor detection technique
Octreotide scanning
Original pathological diagnosis
Revised pathological diagnosis
Followup
Case
19 M
2.5
None
Femoral head
Magnetic resonance imaging
Positive
Nonspecific spindle cell tumor
PMTMCT
Recurrence due to surgery residue and total hip arthroplasty performed at 1.5 m. No further recurrence and normal chemistry at 2.1 y
Case
43 F
4
Vertebral compression fracture (3 cm shorter in height); bilateral metacarpus and bilateral pubis fracture
Temporal bone and sphenoid bone
Octreotide scanning
Positive
PMTMCT
PMTMCT
Unresectable recurrence at 3 m. With carotid artery and cavernous sinus inflicted, no further surgery could be performed. No effect of octreotide therapy. Followup 1.5 y
Case
32 F
3.5
Multiple rib fractures
Soft tissue between the second and third metatarsal bone
Palpation
NA
Giant cell tumor of tendon sheath
PMTMCT
No recurrence and normal chemistry at 7.2 y
Case
32 M
10
Vertebral compression fracture (7 cm shorter in height); bilateral femoral heads necrosis; femoral neck fracture
Fifth metatarsal bone
Ultrasound
Positive
Fibroma of tendon sheath
PMTMCT
Local recurrence at 2.5 y, reoperation performed and normal chemistry at 3.5 y
Case
36 M
1.5
Multiple rib fractures
Lateral thigh
Palpation
Positive
PMT
PMTMCT
No recurrence and normal chemistry at 1.8 y
Case
40 F
6
None
Subcutaneous tissue of the low back
Palpation
NA
Hemangioendothelioma
PMTMCT
No recurrence and normal chemistry at 8.0 y
Case
43 F
4.5
Vertebral compression fracture (15 cm shorter in height); rib fracture